[Moreno-García S] Servicio de Medicina Preventiva, Hospital Universitario Severo Ochoa, Leganés, Spain. [Gonzaléz-Recio P] Escuela Nacional de Sanidad (ENS), Instituto de Salud Carlos III, Madrid, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Donat M] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Iniesta C] Sociedad Española Interdisciplinaria del SIDA (SEISIDA), Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. [Folch C] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Institut Català d'Oncologia (ICO), Departament de Salut, Badalona, Spain. Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, Badalona, Spain. [Alonso-Colón M] Escuela Nacional de Sanidad (ENS), Instituto de Salud Carlos III, Madrid, Spain. Programa de Doctorado en Ciencias Biomédicas y Salud Pública, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain
Departament de Salut
2025-08-18T10:53:52Z
2025-08-18T10:53:52Z
2025-07-07
Prevención del VIH; Disparidades en la salud pública; Salud de las personas transgénero
HIV prevention; Public health disparities; Transgender health
Prevenció del VIH; Disparitats en salut pública; Salut transgènere
HIV continues to be a global public health challenge, especially in transgender and non-binary people (TGNB). Despite the high effectiveness of Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) in reducing HIV transmission, their implementation in this population is unknown. This study describes PrEP and PEP awareness, knowledge of how to access, and use and identifies the factors associated among the TGNB population living in Spain. Data from 1468 participants in Transaludes, a national online survey aimed at TGNB people living in Spain, were analysed. The prevalence of awareness, knowledge of how to access both PrEP and PEP through the public healthcare system, and use of each strategy were estimated. Factors associated with awareness and use were analysed using Poisson regressions with robust variance. A total of 50.5% were aware of PrEP, 14.7% knew how to access PrEP, 2.8% had used it and 1.6% currently, mostly on a daily regimen. A total of 32.5% were aware of PEP, only 13.2% knew how to access PEP and 1.6% had used it, mostly once. Awareness of both strategies was associated with being a non-binary person assigned male at birth (AMAB) or trans woman, being foreign, having a university degree, having undergone biomedical transition and in the past year, having condomless sex with one partner and having engaged in sex work. Use was associated with being older, living in large cities, and in the past year, having condomless sex with two or more partners, having engaged in sex work, and having an STI diagnosis. Awareness of PrEP is moderate, while that of PEP is lower; in both cases, there is a high lack of knowledge about how to access them, and use of both strategies is low. Disparities, particularly among certain subgroups, such as trans men, younger TGNB, those with low educational level and those living in smaller cities, reflect structural inequities in access to both strategies. Targeted and tailored strategies, including campaigns to improve awareness and access to these prevention tools are needed to reduce these gaps within TGNB populations and achieve the goals for ending the HIV epidemic.
This study was funded by Institute Health Carlos III, Strategic Action in Intramural Health 2022 [PI22/00018] and by the Government Delegation for the National Plan on Drugs, Spain (DGPNSD) [EXP2022/008906].
Article
Versió publicada
Anglès
Infeccions per VIH; Persones transgènere; Assistència sanitària; DISEASES::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections; PUBLIC HEALTH::Population Studies in Public Health::Population::Persons::Minority Groups::Sexual and Gender Minorities::Transgender Persons; HEALTH CARE::Health Services Administration::Patient Care Management::Delivery of Health Care::Healthcare Disparities; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH; SALUD PÚBLICA::Estudios Poblacionales en Salud Pública::Población::personas::grupos minoritarios::minorías sexuales y de género::personas transgénero; ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::prestación sanitaria::disparidades en la atención sanitaria
BioMed Central
International Journal for Equity in Health;24(1)
https://www.doi.org/10.1186/s12939-025-02574-4
Attribution-NonCommercial 4.0 International
https://creativecommons.org/licenses/by/4.0/
Articles científics - DS [408]